⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALDX News
Aldeyra Therapeutics, Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Aldeyra Therapeutics, Inc. (ALDX) And Encourages Stockholders to Connect
accessnewswire.com
ALDX
Aldeyra Therapeutics, Inc. (ALDX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
ALDX
Form 8-K
sec.gov
ALDX
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Pomerantz LLP – ALDX
accessnewswire.com
ALDX
Pomerantz LLP Notifies Shareholders of Lawsuit Filed Against Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
businesswire.com
ALDX
ALDX UPCOMING DEADLINE : The Gross Law Firm Alerts Aldeyra Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
globenewswire.com
ALDX
ALDX DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Aldeyra Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 29 Deadline in Securities Class Action First Filed by the Firm - ALDX
accessnewswire.com
ALDX
ALDX DEADLINE - FINAL REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Aldeyra Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit Today
accessnewswire.com
ALDX
Pomerantz LLP Notifies Investors of Class Action Lawsuit Against Aldeyra Therapeutics, Inc. – ALDX
accessnewswire.com
ALDX